Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
A method for treating the diabetic nephropathy provides for the use of Sulodexid in the form of intramuscular injections at a dose of 600 LRU (lipoprotein lipase units) for 10 days followed by oral administration of the drug at a dose of 250 LRU twice a day for 3 months.
UAU201000247U2010-01-132010-01-13Method for treating diabetic nephropathy
UA50960U
(en)